Common use of Pharmacovigilance Agreement Clause in Contracts

Pharmacovigilance Agreement. Either Party may terminate a particular Study under this Agreement immediately upon written notice to the other Party if (a) the Parties do not execute a Pharmacovigilance Agreement for such Study within the timeframe set forth in Section 4.5 or (b) the terminating Party determines in good faith that such Study represents an unjustified risk to the safety of patients in the applicable Study Field.

Appears in 2 contracts

Samples: Supply and Non Exclusive License Agreement (MAIA Biotechnology, Inc.), Supply and Non Exclusive License Agreement (MAIA Biotechnology, Inc.)

AutoNDA by SimpleDocs

Pharmacovigilance Agreement. Either Party may terminate a particular Study under this Agreement immediately upon written notice to the other Party if (a) the Parties do not execute a Pharmacovigilance Agreement for such Study within the timeframe set forth in Section 4.5 or (b) the terminating Party determines in good faith that such Study represents an unjustified risk to the safety of patients in the applicable Study Field.Section

Appears in 1 contract

Samples: Supply and Non Exclusive License Agreement (MAIA Biotechnology, Inc.)

Pharmacovigilance Agreement. Either Party may terminate a particular Study under this Agreement immediately upon written notice to the other Party if (a) the Parties do not execute a Pharmacovigilance Agreement for such Study within the timeframe set forth in Section 4.5 or (b) the terminating Party determines in good faith that such Study represents an unjustified risk to the safety of patients in the applicable Study Fieldmay unreasonably adversely affect patient safety.

Appears in 1 contract

Samples: Supply and Non Exclusive License Agreement (Checkmate Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

Pharmacovigilance Agreement. Either Party may terminate a particular Study under this Agreement immediately upon written notice to the other Party if (a) the Parties do not execute a Pharmacovigilance Agreement for such Study within the timeframe set forth in Section 4.5 or (b) the terminating Party determines in good faith that such Study represents an unjustified risk to the safety of patients in the applicable Study Fieldmay unreasonably affect patient safety.

Appears in 1 contract

Samples: Supply and Non Exclusive License Agreement (Angion Biomedica Corp.)

Time is Money Join Law Insider Premium to draft better contracts faster.